Display options
Share it on

J Ophthalmic Vis Res. 2015 Oct-Dec;10(4):417-23. doi: 10.4103/2008-322X.176892.

Predictive Value of Pupillary Response to Mydriatic Agents for Diagnosis of Retinopathy of Prematurity.

Journal of ophthalmic & vision research

Ramak Roohipoor, Mohammad Riazi-Esfahani, Nazanin Ebrahimiadib, Reza Karkhaneh, Mohammad Zarei, Sara Besharat, Fariba Ghassemi, Mohammad Reza Ostovaneh

Affiliations

  1. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
  2. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Department of Ophthalmology, Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran.
  3. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  4. Department of Cardiology, Johns Hopkins University, Baltimore, Maryland, USA.

PMID: 27051486 PMCID: PMC4795391 DOI: 10.4103/2008-322X.176892

Abstract

PURPOSE: To evaluate the feasibility of screening for retinopathy of prematurity (ROP) by assessing the pupillary response to mydriatics.

METHODS: This observational case series included 134 eyes of 67 premature infants with birth weight less than 2,000 grams and gestational age less than 33 weeks. A composite eye drop composed of phenylephrine 1%, tetracaine and tropicamide 0.5% was applied 3 times within 5-minute intervals and pupil diameters were measured. The eyes were examined by experienced ROP specialists using an indirect ophthalmoscope. Zone and stage of ROP, presence of plus disease and need for treatment were recorded. The relationship between the pupillary response to mydriatics, and presence and severity of ROP was evaluated. Logistic regression was used for statistical analysis.

RESULTS: According to receiver operating characteristic (ROC) curve analysis, final pupil diameter after mydriatic administration was found the most accurate factor among other factors to recognize ROP zone I from zones II and III (Area under ROC: 0.92 [95%CI: 0.85-0.98]). The best cutoff value for final pupil diameter was 5.6 mm, because it could differentiate involvement of zone I from zones II and III with sensitivity of 80% and specificity of 100%.

CONCLUSION: Response of the pupil to mydriatic eye drops may be useful as a less invasive method for rough estimation of ROP in high risk babies who need emergent attention; however, it cannot be considered as a screening test due to its low sensitivity.

Keywords: Mydriatic Eye Drops; Predictive Value; Pupillary Response; Retinopathy of Prematurity; Screening

References

  1. Arch Ophthalmol. 2012 Jun;130(6):720-3 - PubMed
  2. JAMA Ophthalmol. 2013 Jan;131(1):62-6 - PubMed
  3. J Med Assoc Thai. 2009 Nov;92(11):1458-62 - PubMed
  4. Adv Neonatal Care. 2009 Jun;9(3):99-110 - PubMed
  5. Arch Ophthalmol. 2005 Jul;123(7):991-9 - PubMed
  6. Biol Neonate. 1998;73(1):1-9 - PubMed
  7. J Trop Pediatr. 2007 Feb;53(1):52-4 - PubMed
  8. Korean J Ophthalmol. 2009 Dec;23(4):291-5 - PubMed
  9. Pediatr Res. 2010 Jan;67(1):1-8 - PubMed
  10. J Neuroophthalmol. 2006 Mar;26(1):25-9 - PubMed
  11. J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73 - PubMed
  12. Arch Soc Esp Oftalmol. 2013 Feb;88(2):43-4 - PubMed
  13. Vestn Oftalmol. 2002 Nov-Dec;118(6):5-9 - PubMed
  14. Acta Ophthalmol Scand. 1998 Aug;76(4):413-6 - PubMed
  15. J AAPOS. 2009 Dec;13(6):618-20 - PubMed
  16. Ophthalmology. 2012 Mar;119(3):634-41 - PubMed
  17. Biol Neonate. 2004;86(3):195-200 - PubMed
  18. Adv Neonatal Care. 2011 Aug;11(4):291-7 - PubMed

Publication Types